Startup Claims Discovery of Drug to Make Blood Young Through Combination Therapy
What happened
- A startup named Generation Lab claims to have found a rejuvenation treatment called “1 Generation,” which is an injectable combination of two existing drugs.
- This treatment reportedly blocks the systemic spread of aging in the bloodstream and restores health and youth to multiple tissues.
- The company is offering access to this treatment to a limited private cohort under close physician supervision.
- The research is based on the work of founder Irina Conboy, who explored methods like parabiosis (blood exchange between animals) to understand age reversal.
- Participants in early testing reported benefits such as improved vision, longer sessions, better erections than Viagra, and increased bowel movements.
Why it matters for me
This development touches upon the long-standing quest for longevity and anti-aging treatments. While the claims are highly publicized, there are significant questions regarding the evidence and the process. The research involves complex biological mechanisms, and while some doctors express optimism, others remain skeptical about the unproven nature of the results.
What to remember
- The treatment is based on a combination of existing drugs, not bodily fluid exchange.
- Generation Lab plans a larger study involving over a hundred people, but access is currently limited.
- The company keeps the names of the drugs confidential to prevent imitation and seek FDA exclusivity.
Source: Original article
Source: www.technologyreview.com
